Healthcare / Biotechnology & Medical ResearchUpdated 2026-05-10 22:07 UTC

WSE/MDB stock hub

WSE/MDB has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

WSE/MDBis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

29.8M

Warsaw Stock Exchange

Market data

Price

Recent price action with selectable time range.

WSE/MDBWSE/MDB

—

Loading chart…

In the news

Latest news · WSE/MDB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-35.5

P25 n/aP50 n/aP75 n/a

ROIC-19.5

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All WSE/MDB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

157

Groups with data

Currency

PLN

Showing 157 of 157 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Poland
Country code	PL
Employees	14
Employees Change	-6%
Employees Change Percent	-30
Enterprise value	PLN 33.5M
Exchange	Warsaw Stock Exchange
Financial currency	PLN
First seen	2026-05-10
Industry	Biotechnology & Medical Research
Last refreshed	2026-05-10
Market cap	PLN 29.8M
Price	PLN 0.44
Price currency	PLN
Rev Per Employee	8,564.29x
Sector	Healthcare
Sic	8731
Symbol	wse/MDB
Website	https://medicofarmabiotech.pl

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-7.49%
EV Earnings	-15.01x
EV/Sales	279.24x
P/B ratio	5.24x
P/S ratio	248.33x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBITDA Margin	-173.66%
Gross Profit	PLN -1.1M
Net Income	PLN -2.2M
Pretax Margin	-1,860.32%
Profit Per Employee	PLN -159,323
ROA	-7.35
Roa5y	-6.92
ROCE	-16.82
ROE	-35.52
Roe5y	-22.14
ROIC	-19.51
Roic5y	-15.36

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-3.57%
Cagr15y	-5.35%
Cagr1y	51.6%
Cagr3y	-25.51%
Cagr5y	-34.38%
Revenue Growth	-90.21x
Revenue Growth3 Y	-69.56x
Revenue Growth5 Y	-49.5x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	PLN 0.01
Assets	PLN 14.2M
Cash	PLN 1,742
Current Assets	PLN 5.1M
Current Liabilities	PLN 4.1M
Debt	PLN 3.7M
Debt Equity	PLN 0.65
Equity	PLN 5.7M
Interest Coverage	-2.75
Liabilities	PLN 8.5M
Long Term Assets	PLN 9.1M
Long Term Liabilities	PLN 4.4M
Net Cash	PLN -3.7M
Net Cash By Market Cap	PLN -12.45
Net Debt Equity	PLN 0.65
Tangible Book Value	PLN 5.6M
Tangible Book Value Per Share	PLN 0.08
WACC	9.69

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.25
Net Working Capital	PLN 1M
Quick ratio	1.25
Working Capital	PLN 1M
Working Capital Turnover	PLN 0.69

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-30.48%
1Y total return	51.56%
200-day SMA	0.49
3Y total return	-58.68%
50-day SMA	0.47
50-day SMA vs 200-day SMA	50under200
5Y total return	-87.83%
All Time High	8.5
All Time High Change	-94.85%
All Time High Date	2020-11-13
All Time Low	0.18
All Time Low Change	143.33%
All Time Low Date	2018-12-20
ATR	0.03
Beta	0.91
Beta1y	1.64
Beta2y	0.92
Ch YTD	9.77
High	0.44
High52	1.4
High52 Date	2025-09-11
High52ch	-68.71%
Low	0.43
Low52	0.24
Low52 Date	2025-05-20
Low52ch	85.59%
Ma50ch	-6.85%
Price vs 200-day SMA	-10.5%
RSI	38
RSI Monthly	43.9
RSI Weekly	45.35
Sharpe ratio	0.84x
Sortino ratio	3.18
Tr YTD	9.77
Tr15y	-56.2%
Tr1m	-12.4%
Tr1w	-6.01%
Tr3m	-10.43%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	PLN -1.7M
Operating margin	-1,418.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	10,137,659%
Net Borrowing	979,060
Shares Out	67,978,300
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	25,372.65x
Bv Per Share	0.08
Ch10y	-30.48
Ch15y	-56.2
Ch1m	-12.4
Ch1w	-6.01
Ch1y	51.56
Ch3m	-10.43
Ch3y	-58.68
Ch5y	-87.83
Ch6m	-15.12
Change	-2.67%
Change From Open	-0.45
Close	0.45
Days Gap	-2.22
Depreciation Amortization	1,492,833
Dollar Volume	7,434.6
Earnings Date	2026-05-12
EBIT	PLN -1.7M
EBITDA	PLN -208,222
EPS	PLN -0.03
F Score	2
Financing CF	979,060
Fiscal Year End	December
Founded	2,001
Is Primary Listing	1
Last Earnings Date	2026-03-20
Last Report Date	2025-12-31
Last Split Date	2011-11-08
Last Split Type	Reverse
Ma150	0.5
Ma150ch	-13.13%
Ma20	0.48
Ma20ch	-7.91%
Net CF	-4,497
Next Earnings Date	2026-05-12
Open	0.44
Position In Range	75
Ppne	9,029,173
Price Date	2026-05-08
Ptbv Ratio	5.28
Relative Volume	0.67x
Revenue	119,900x
Tr6m	-15.12%
Volume	16,974
Z Score	0.59

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does WSE/MDB pay a dividend?

Capital-return profile for this ticker.

Performance

WSE/MDB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Technical

WSE/MDB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

38.0

Neutral momentum band

Price vs 200-day MA

-10.5%

50/200-day relationship not available

Beta (5Y)

0.91

Moves roughly with the market

Sharpe ratio

0.84

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About WSE/MDB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current wse/MDB stock rating?

wse/MDB is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full wse/MDB analysis?

The full report lives at /stocks/wse/MDB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for wse/MDB?

The latest report frames wse/MDB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the wse/MDB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.